期刊文献+

木糖氧化产碱杆菌在临床上的感染状况与耐药谱分析 被引量:1

infection and drug resistance of achromobacter xylosoxidans
原文传递
导出
摘要 木糖氧化产碱杆菌是一种非发酵革兰阴性杆菌,属于产碱杆菌属,是一种条件致病菌,广泛存在于自然界,在人类的胃肠道也可以分离到此细菌,较少引起人类感染性疾病.近年来,由木糖氧化产碱杆菌引起感染的报道日渐增加,病死率高达47.5%[1],受到广泛关注.本文回顾性研究了我院2008 - 2010年木糖氧化产碱杆菌感染情况和耐药谱,希望为临床医师和临床微生物工作者提供帮助.
出处 《中华临床感染病杂志》 CAS 2011年第5期-,共3页 Chinese Journal of Clinical Infectious Diseases
  • 相关文献

参考文献8

  • 1Tens D;González-Praetorius A;Pérez-Balsalobre M.Urinary tract infection due to Achromobacter xylosoxidans:report of 9 cases[J],2008(02).
  • 2郑悦,赵松,李文雄,王小文.33例ICU木糖氧化产碱杆菌感染的临床特点及耐药性分析[J].中国医刊,2008,43(12):61-62. 被引量:2
  • 3Olshtain-Pops K;Block C;Temper V.An outbreak of Achromobacter xylosoxidans associated with ultrasound gel used during transrectal ultrasound guided prostate biopsy,2011(01).
  • 4Reddy AK;Garg P;Shah V.Clinical,microbiological profile and treatment outcome of ocular infections caused by Achromobacter xylosoxidans[J],2009(10).
  • 5Lambiase A;Catania MR;del Pezzo M.Achromobacter xylosoxidans respiratory tract infection in cystic fibrosis patients[J],2011(08).
  • 6欧阳金鸣,康辉,王倩,邓宇欣.医院非发酵菌感染及耐药性分析[J].中国实验诊断学,2006,10(6):644-647. 被引量:8
  • 7董晓勤,周田美,施新颜,吴盛海,范建中,汪涛.非发酵菌感染的临床分布和耐药谱分析[J].中华医院感染学杂志,2004,14(7):809-811. 被引量:48
  • 8Shie SS;Huang CT;Leu HS.Characteristics of Aehromobacter xylosoxidans hacteremia in northern Taiwan,2005(04).

二级参考文献17

  • 1廖雪梅,韩志伟.医院非发酵菌感染及耐药性分析[J].实用医院临床杂志,2004,1(3):88-90. 被引量:8
  • 2董晓勤,周田美,施新颜,吴盛海,范建中,汪涛.非发酵菌感染的临床分布和耐药谱分析[J].中华医院感染学杂志,2004,14(7):809-811. 被引量:48
  • 3张卫英,高英,吴巍,董晓勤,周田美,余道军.木糖氧化产碱菌的耐药性分析[J].中华医院感染学杂志,2006,16(5):589-591. 被引量:8
  • 4Spear JB, Fuhrer J, Kirby BD. Achromobacter xylosoxidans ( Alcaligenes xylosoxidans subsp, xylosoxidans ) bacteremia associated with a well-water source: case report and review of the literature [J]. Clln Microbiol, 1988,26 ( 3 ) : 598 - 599.
  • 5Shie SS, Huang CT, Leu HS. Characteristics of Achromobacter xylosoxidans bacteremia in northern Taiwan [ J ]. Microbiol Immunol Infect, 2005,38 (4) : 277 - 282.
  • 6Mueller EW, Hanes SD, Croce MA, et al. Effect from multiple episodes of inadequate empiric antibiotic therapy for ventilator-associated pneumonia on morbidity and mortality among critically ill trauma patients [ J ] . Trauma, 2005,58 ( 1 ) : 94 - 101.
  • 7[3]Vay C,Almuzara M,Mattera J,et al.Evaluation of API 20 NE (version 6.0) in rare Gram-negative non-glucose-fermenting bacilli[J] Rev Argent Microbiol,2003,35(3): 133-137.
  • 8National Committee for Clinical Laboratory Standards.Performance Standards for Antimicrobioal Susceptibility Testing; the fourteenth Informationl Supplement[S],M100-S14:NCCLS,2004,24(1).
  • 9Weiss K,Restieri C,Carolis ED,et al.Comparative activity of new quinolones against 326 clinical isolates of Stenotrophomonas maltophilla[J].Antimicrob.Chemother,2000,45:363.
  • 10Giovanni Pietro Gesu,Federico Marchetti.Levofloxacin and Ciprofloxacin In Vitro Activities against 4,003 Clinical Bacterial Isolates Collected in 24 Italian Laboratories[J].Antimicrob.Agents Chemother,2003,47:816.

共引文献54

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部